Adrian JohnsonTLDR: UK-based startup Evaro has raised €1.3 million in a seed funding round led by Cornerstone VC and Exceptional Ventures. The digital health startup offers AI-powered clinical and drug prescription services for minor conditions, with a mission to make healthcare accessible and affordable. The funds will be used to expand Evaro’s services in the B2B market and introduce a plug-and-play product for consumer brands to offer managed medication prescription services.
Evaro, founded in 2018 by emergency doctor Dr. Thuria Wenbar and pharmacist researcher Dr. Oskar Wendowski, offers direct-to-patient AI-driven consultations and private prescription services. The startup aims to assist 10 million people in getting quicker treatment for minor health conditions by integrating pharmaceutical services into consumer brands. Evaro claims to be a pioneer in the emerging pharma-infrastructure-as-a-service category.
The company utilizes AI and machine learning trained on 13.5 million patient records for consultations and prescriptions. The platform prioritizes patient safety with a regulatory-compliant process, including asynchronous consultations, answer manipulation detection, and scrutiny of drug orders for safe dosages. The funding will also support obtaining a Care Quality Commission (CQC) license for comprehensive patient care.
